A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

If Portage is not in compliance with the continued listing standards by June 9, 2025, or if Portage does not make progress ...

The aggregate gross proceeds to the Company from the offering were approximately $1,050,000, before deducting the placement ...

National Testing Agency (NTA) has invited Online Applications for Graduate Aptitude Test- Biotechnology (GAT-B) – 2025, a ...

Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, ...

EVENTS DURING THE FOURTH QUARTEREuropean Patent Office granted Active Biotech's patent application for eye drop formulation of laquinimod (October 23)Active Biotech's clinical trial of tasquinimod in ...

MAIA Biotechnology, Inc. (NYSEAMERICAN: MAIA) disclosed information relating to its Phase 2 THIO-101 trial in advanced non-small cell lung cancer through a press release on February 4, 2025. According ...

The IT workforce reductions come as Moderna’s chief information officer Brad Miller departs after a two-year stint. Story Feb. 13 - Encoded Therapeutics: The gene therapy biotech is laying off ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The ...

All high schools, including Elliot Alternative, offer the design, visual and media arts pathway. Davis, Downey, Gregori and ...

Human BioSciences, a leader in biotechnology and wound care solutions, is tackling one of our most pressing health challenges ...